Detection of tumor tiSsue in pEritoneal metastases of coLorectal origin using a VEGF-targeted optical fluoresCent imaging tracer during diagnosTic laparoscopy: a single center phase I study

ABSTRACT: Interventions: Single bolus of Bevacizumab-IRDye800CW (2.5 mg, 4.5 mg, 10 mg or 25 mg) intravenously. Primary outcome(s): Degree of fluorescent signal levels (defined as Tumor-to-Background Ratio [TBR]) per dose group, consisting of the difference in signal levels between colorectal PM and normal benign surrounding tissue. Study Design: N/A: single arm study, Open (masking not used), N/A , unknown, Other

DISEASE(S): Colorectal Peritoneal Metastases (pm)

PROVIDER: 2442208 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR